Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 37,924 | 39,622 | 40,264 | 39,657 | 36,693 |
| Cost of Goods | 15,081 | 15,491 | 17,485 | 14,795 | 14,889 |
| Gross Profit | 22,843 | 24,131 | 22,779 | 24,862 | 21,804 |
| Operating Expenses | 35,477 | 31,289 | 29,062 | 29,038 | 26,247 |
| Operating Income | -12,553 | -6,667 | -5,798 | -3,381 | -3,554 |
| Other Income | 539 | 276 | 436 | 96 | -154 |
| Pre-tax Income | -12,014 | -6,391 | -5,362 | -3,285 | -3,708 |
| Income Tax | -1,664 | -1,483 | -1,187 | -442 | -775 |
| Net Income Continuous | -10,350 | -4,908 | -4,175 | -2,843 | -2,933 |
| Net Income | $-10,350 | $-4,908 | $-4,175 | $-2,843 | $-2,933 |
| EPS Basic Total Ops | -0.71 | -0.33 | -0.29 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | -0.71 | -0.34 | -0.29 | -0.20 | -0.20 |
| EPS Diluted Total Ops | -0.71 | -0.33 | -0.29 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | -0.71 | -0.34 | -0.29 | -0.20 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.21 | -0.05 | N/A | N/A |
| EBITDA(a) | $-9,002 | $-3,001 | $-2,303 | $328 | $63 |